All News

congress

US Senate Introduces the Safe Step Act

d ACR

The American College of Rheumatology (ACR) today commended leaders in the United States Senate for introducing the bipartisan Safe Step Act of 2021 (S. 464), new legislation that would place reasonable limits on insurer use of step therapy.

Read Article
psoriatic.PIP_.JPG

Upadacitinib Clinical Efficacy in Psoriatic Arthritis

d Jack Cush, MD

McInnes and colleagues have published the results of the SELECT - PsA trial in NEJM showing updacitinib (UPA) to be superior to placebo in active psoriatic arthritis (PsA) patients, with 15 mg UPA equal to adalimumab (ADA) and 30 mg UPA qd being superior to ADA.

Read Article
heart-attack.jpg

Inflammatory Conditions Up the Risk of Premature Myocardial Infarction

d Jack Cush, MD

The European Journal of Preventive Cardiology reports that younger patients with their first myocardial infarction before age 50 yrs have a higher risk of having a systemic inflammatory disease (SIDs) and higher rates all-cause mortality.

Read Article
uveitis eye iritis

HLA B27 Iritis - RNL 2021 Highlights

d Rachel Tate, DO

The Spondyloarthritis Advances pod presented during the RheumNow Live 2021 conference featured three speakers, including an excellent lecture by Dr. Robert Wang, ophthalmology, on HLA B27 iritis and practical tips for rheumatologists. 

Read Article
Fracture.spine_.op_.jpg (keep)

Aortic Calcification and Lumbar Fracture Risk in Older Men

d Jack Cush, MD

Fractures of the spine and abdominal aortic calcification (AAC) can both be visualized with spinal imaging; a new report shows that finding both radiographic vertebral fracture and AAC on the same lateral spine images may predict the risk of future incident major osteoporotic fracture i

Read Article
Matched cohort Nurses’ Health Study looked at 283 pre‐RA pts (mean 9.7 years before RA Dx) and and 842 controls; 21% pre‐RA were ACPA+. ACPA+ was associated with increased risk of COPD (HR 3.04) that was not seen in ACPA- pts. https://t.co/HNB11eAiva

Links:

Dr. John Cush RheumNow ( View Tweet)

Dr. Olga Petryna ( @drpetryna) weighing the future Rx in RA by Dr. Fleischmann: -CD22, new IL6i & GM-CSF show promises but far form being available -bDMARD or tsDMARD after MTX but work better wMTX -JAKS better choice for mono-therapy but safety is a concern #RNL2021

Dr. John Cush RheumNow ( View Tweet)

#RNL2021 coverage from @doctorRBC ACR’s conditional recommendations for tx of specific RA populations #RheumNow https://t.co/3uo9x42bPX
Dr. John Cush RheumNow ( View Tweet)
Retrospective study of 267 adults w/ Henoch-Schönlein purpura (AKA IgA vasculitis (IgAV) shows more arthritis, enteritis & renal Dz, higher comorbidity scores (2.6 vs1.5) & higher risk of Serious infx (OR 8.4) and death (MRR 2.06) than gen population https://t.co/ihK6JPbLFm

Links:

Dr. John Cush RheumNow ( View Tweet)

News Feature: Hypertension Unaffected by Urate Lowering Therapy Does uric acid contribute to the risk of hypertension (HTN)? A recent cohort trial shows that allopurinol in young adults does not sufficiently lower blood pressure (BP). https://t.co/PAMkgCc2DS #RheumNow https://t.co/ar7OiWKVQj

Links:

Dr. John Cush RheumNow ( View Tweet)
263 RA patients with ILD were treated w/ Abatacept (ABA mono, ABA+MTX or ABA+nonMTX) - all improved their DAS28, stablized their FVC, DLCO, CHest CT; Only difference was that steroid sparing best when ABA used in combo. https://t.co/11vJCWOdSG https://t.co/yMF6imuFMV

Links:

Dr. John Cush RheumNow ( View Tweet)
Abstract presented 10/20 at American Society Nephrology mtg show IV Pegloticase use in 136 ESRD dialysis pts (Rx by Rheums 68%). Pts were 73% males, avg age 57 years, More on hemodialysis [79%] than peritoneal dialysis [17%]. Pts RCV ~13 infusions. https://t.co/SFO8duqiy8

Links:

Dr. John Cush RheumNow ( View Tweet)

Great coverage of #RNL2021 from Dr. Robert Chao @doctorRBC Fascinating talk by Dr. Robert Wang on uveitis. Pearls: -Anterior uveitis with hypopyon, will be B27+ -Hypopyon can be 2/2 Behcets and endopthalmitis -work up for Uveitis: B27, ACE/CXR, syphilis test #RNL2021 https://t.co/9DdNaAt7lx
Dr. John Cush RheumNow ( View Tweet)
News Feature: Psoriatic Disease Management - #RNL2021 Highlights This year’s coverage of psoriatic arthritis included an overview of the latest therapeutic options, a discussion on psoriasis specifically, and the epidemiology of psoriatic arthritis. https://t.co/wJ0pFgANhy https://t.co/SJezq1O7T4

Links:

Dr. John Cush RheumNow ( View Tweet)
The Reflecting Rheum: Top Publications from 2020 Covering SpA and Still’s Disease Sponsored by Novartis Medical Affairs Listen to a panel of experts share their views on top spondyloarthritis and Still’s disease publications from 2020. View Now: https://t.co/Kp2drDS1x3 https://t.co/Y1PilF0Syg

Links:

Dr. John Cush RheumNow ( View Tweet)
From Dr. Petryna ( @DrPetryna ) on Pneumonia & RA #RNL2021 : -PNA most common hospital inf in RA and main cause of hosp mortality -seropositivity assoc w/increase risk of PNA -COPD+RA bad combo: increase PNA & mortality #RheumNow https://t.co/IgXfJTMrcn
Dr. John Cush RheumNow ( View Tweet)
Have you listened to this week's podcast? Dr. Jack Cush reviews the news, FDA Denials and journal articles from the past week on RheumNow. Download wherever podcasts are available. https://t.co/Twy04G9RU1 https://t.co/NSsR2tFq5i

Links:

Dr. John Cush RheumNow ( View Tweet)
Metanalysis of 32 studies shows most forms of arthritis assoc w/ incr risk of CVA (ischemic stroke: RR=1.53 or hemorrhagic stroke: RR=1.45), esp for RA (RR=1.38), AS (RR=1.49), PsA (RR=1.33), gout (RR=1.4) --risk higher with age <45 years (RR=1.46) https://t.co/YDiebrqtbi

Links:

Dr. John Cush RheumNow ( View Tweet)

From @KDAO2011 for #RNL2021 Is it better to taper the steroids or leave it? SEMIRA study. Tapering off low dose steroids cause more flares and more treatment side effects. Dr. Buttgereit says keep your low dose steroids (prednisone 5 mg/day or less) https://t.co/FpQnxUKWwF

Links:

Dr. John Cush RheumNow ( View Tweet)

News Feature: Serious Infections Still Common in Vasculitis Serious infections occurred more frequently among patients with ANCA-associated vasculitis who were given induction therapy with cyclophosphamide compared with rituximab (Rituxan). #RheumNow https://t.co/dTL6cReg8s https://t.co/U2sbEzd5DX

Links:

Dr. John Cush RheumNow ( View Tweet)
×